Stepien T, Lawnicka H, Komorowski J, Stepien H, Siejka A.
Journal Article 2010; 31(6): 852-856 PubMed PMID: 21196925 Keywords: Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Growth Hormone-Releasing Hormone:pharmacology, Humans, Interleukin-17:secretion, Leukocytes, Mononuclear:drug effects,. CitationOBJECTIVES: Growth hormone-releasing hormone (GHRH) plays a crucial role in the secretion of GH from the pituitary, acts as a growth facto.....
Stepien T, Lawnicka H, Komorowski J, Stepien H, Siejka A. Growth hormone-releasing hormone stimulates the secretion of interleukin 17 from human peripheral blood mononuclear cells in vitro. Neuro Endocrinol Lett. 2010 Jan; 31(6): 852-856
Winczyk K, Fuss-Chmielewska J, Lawnicka H, Pawlikowski M, Karasek M.
Journal Article 2009; 30(5): 657-662 PubMed PMID: 20035258 Keywords: Animals, Cell Line, Tumor, Colonic Neoplasms:metabolism, Humans, Melatonin:metabolism, Mice, Receptors, Melatonin:antagonists & inhibitors, Tetrahydronaphthalenes:metabolism, Tryptamines:metabolism,. CitationOBJECTIVE: Our earlier studies have shown that MLT exerts the inhibitory effect on murine cancer via membrane and nuclear receptors. We ha.....
Winczyk K, Fuss-Chmielewska J, Lawnicka H, Pawlikowski M, Karasek M. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Neuro Endocrinol Lett. 2009 Jan; 30(5): 657-662
Winczyk K, Lawnicka H, Pawlikowski M, Kunert-Radek J, Karasek M.
Comparative Study 2006; 27(3): 351-354 PubMed PMID: 16816834 Keywords: Adenocarcinoma:drug therapy, Animals, Antimetabolites, Antineoplastic:pharmacology, Antineoplastic Agents, Hormonal:pharmacology, Antineoplastic Combined Chemotherapy Protocols:pharmacology, Breast Neoplasms:drug therapy, Cell Line, Tumor, Cell Proliferat. CitationOBJECTIVES: Melatonin may influence directly tumor cells through the specific binding sites. The best known melatonin binding sites are me.....
Winczyk K, Lawnicka H, Pawlikowski M, Kunert-Radek J, Karasek M. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells. Neuro Endocrinol Lett. 2006 Jun; 27(3): 351-354
Winczyk K, Pawlikowski M, Lawnicka H, Kunert-Radek J, Spadoni G, Tarzia G, Karasek M.
Journal Article 2002; 23(Suppl 1): 50-54 PubMed PMID: 12019352 Keywords: Animals, Antineoplastic Agents:pharmacology, Antioxidants:pharmacology, Apoptosis:drug effects, Bromodeoxyuridine, Cell Division:drug effects, Colonic Neoplasms:drug therapy, Indoles:pharmacology, Ligands, Melatonin:antagonists & inhibitors, Mice, Mice, I. CitationOBJECTIVES: Our previous study suggest that oncostatic action of melatonin (MLT) depends mainly on nuclear RZR/ROR receptors. However, we .....
Winczyk K, Pawlikowski M, Lawnicka H, Kunert-Radek J, Spadoni G, Tarzia G, Karasek M. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo. Neuro Endocrinol Lett. 2002 Apr; 23(Suppl 1): 50-54
Lawnicka H, Galant-Gdula A, Motylewska E, Komorowski J, Swietoslawski J, Stepien H.
Journal Article 2018; 38(8): 565-564 PubMed PMID: 29504734 CitationBACKGROUND: Though vitamin D deficiency is a global problem with wide spectrum of severe public health consequences, inadequate vitamin D .....
Lawnicka H, Galant-Gdula A, Motylewska E, Komorowski J, Swietoslawski J, Stepien H. Estimation of vitamin D status in patients with secondary and primary hypothyroidism of different etiology. Neuro Endocrinol Lett. 2018 Feb; 38(8): 565-564